2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery
- PMID: 39955230
- PMCID: PMC11947607
- DOI: 10.1016/j.bja.2025.01.015
2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery
Abstract
Clinical practice guidelines consolidate and evaluate all pertinent evidence on a specific topic available at the time of their formulation. The goal is to assist physicians in determining the most effective management strategies for patients with a particular condition. These guidelines assess the impact on patient outcomes and weigh the risk-benefit ratio of various diagnostic or therapeutic approaches. While not a replacement for textbooks, they provide supplementary information on topics relevant to current clinical practice and become an essential tool to support the decisions made by specialists in daily practice. Nonetheless, it is crucial to understand that these recommendations are intended to guide, not dictate, clinical practice, and should be adapted to each patient's unique needs. Clinical situations vary, presenting a diverse array of variables and circumstances. Thus, the guidelines are meant to inform, not replace, the clinical judgement of healthcare professionals, grounded in their professional knowledge, experience and comprehension of each patient's specific context. Moreover, these guidelines are not considered legally binding; the legal duties of healthcare professionals are defined by prevailing laws and regulations, and adherence to these guidelines does not modify such responsibilities. The European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Cardiothoracic Anaesthesiology and Intensive Care (EACTAIC) and the European Board of Cardiovascular Perfusion (EBCP) constituted a task force of professionals specializing in cardiopulmonary bypass (CPB) management. To ensure transparency and integrity, all task force members involved in the development and review of these guidelines submitted conflict of interest declarations, which were compiled into a single document available on the EACTS website (https://www.eacts.org/resources/clinical-guidelines). Any alterations to these declarations during the development process were promptly reported to the EACTS, EACTAIC and EBCP. Funding for this task force was provided exclusively by the EACTS, EACTAIC and EBCP, without involvement from the healthcare industry or other entities. Following this collaborative endeavour, the governing bodies of EACTS, EACTAIC and EBCP oversaw the formulation, refinement, and endorsement of these extensively revised guidelines. An external panel of experts thoroughly reviewed the initial draft, and their input guided subsequent amendments. After this detailed revision process, the final document was ratified by all task force experts and the leadership of the EACTS, EACTAIC and EBCP, enabling its publication in the European Journal of Cardio-Thoracic Surgery, the British Journal of Anaesthesia and Interdisciplinary CardioVascular and Thoracic Surgery. Endorsed by the EACTS, EACTAIC and EBCP, these guidelines represent the official standpoint on this subject. They demonstrate a dedication to continual enhancement, with routine updates planned to ensure that the guidelines remain current and valuable in the ever-progressing arena of clinical practice.
Keywords: EACTAIC; EACTS; EBCP; cardiac anaesthesia; cardiac surgery; cardiopulmonary bypass; clinical perfusionist; evidence-based practice; extracorporeal circulation; guidelines; minimally invasive extracorporeal circulation; recommendations.
Copyright © 2025 Alexander Wahba, Gudrun Kunst, Filip De Somer, Henrik Agerup Kildahl, Benjamin Milne, Gunilla Kjellberg, Adrian Bauer, Friedhelm Beyersdorf, Hanne Berg Ravn, Gerdy Debeuckelaere, Gabor Erdoes, Renard Gerhardus Haumann, Tomas Gudbjartsson, Frank Merkle, Davide Pacini, Gianluca Paternoster, Francesco Onorati, Marco Ranucci, Nemanja Ristic, Marc Vives, Milan Milojevic, EACTS/EACTAIC/EBCP Scientific Document Group. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Conflict of interest Adrian Bauer reports a leadership role for LivaNova related to customer meetings for new products. Friedhelm Beyersdorf reports receiving consulting fees from Franz Köhler Chemie, Germany (<10,000 EUR), and honoraria from AtriCure. Friedhelm Beyersdorf also reports leadership roles in EACTS and DGTHG. Filip De Somer reports receiving a grant and consulting fees from LivaNova, both paid to University Ghent. Filip De Somer also reports a leadership position in EBCP (unpaid). Gudrun Kunst reports receiving honoraria from Edwards for contributions to two discussion workshops in 2024 and 2022, and from BioMerieux for a presentation contribution to a webinar. Gudrun Kunst also reports leadership roles for the National Institute of Academic Anaesthesia Royal College of Anaesthesia UK as Grant Officer and Board and Research Council Member, for the Association of Cardiothoracic Anaesthesia and Critical Care UK as Scientific Chair and Board Member, and for the European Board of Cardiovascular Perfusion as Scientific Chair and Board Member. Frank Merkle reports receiving consulting fees and honoraria from LivaNova and Terumo Europe (both to the institution). Benjamin Milne reports receiving consulting fees from Edwards Lifesciences. Milan Milojevic reports receiving a speaker fee from Corcym in relation to ERAS (<1000K) and one from Medtronic in relation to CPB (<1000K). Milan Milojevic also reports a role of Guidelines Program Director at EACTS. Francesco Onorati reports receiving grants from Edwards Lifesciences, and honoraria from Edwards Lifesciences and Abbott. Francesco Onorati reports receiving support from Edwards Lifesciences and Abbott for attending meetings. Francesco Onorati reports participation on an advisory board for the IMPACT and INDURE trials. Francesco Onorati reports leadership positions in EBCTS and the Italian Society of Cardiac Surgery. Francesco Onorati also reports receiving equipment from IPP Med. Davide Pacini reports receiving grants from Artivion, Terumo Aortic, Peters, and Corcym. Davide Pacini reports receiving consulting fees and honoraria from Terumo Aortic and Peters. Davide Pacini reports receiving support for attending meetings from Corcym. Davide Pacini reports participating on the advisory board for the TRACS trial. Davide Pacini also reports leadership positions for the Italian Society of Cardiac Surgery and the Francis Fontan Foundation. Marco Ranucci reports receiving royalties from LivaNova for a GDP monitor patent. Marco Ranucci reports receiving consulting fees from LivaNova as a personal payment, and honoraria from LivaNova and Medtronic as personal payments. Marco Ranucci also reports receiving personal payment from LivaNova for participating on an advisory board.
Figures



References
-
- Kunst G., Milojevic M., Boer C., et al. 2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery. Br J Anaesth. 2019;123(6):713–757. - PubMed
-
- Sousa-Uva M., Head S.J., Thielmann M., et al. Methodology manual for European association for cardio-thoracic surgery (EACTS) clinical guidelines. Eur J Cardiothorac Surg. 2015;48(6):809–816. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical